ヨーロッパのエキソソーム研究製品市場、製品別（機器および消耗品）、適応症別（がんおよび非がん）、用途別（治療薬および診断薬）、エンドユーザー別（病院、臨床検査研究所、研究センター、製薬およびバイオテクノロジー企業、学術機関など）、流通チャネル別（サードパーティの販売代理店、オンライン、直接入札など）の業界動向と2030年までの予測。
ヨーロッパのエクソソーム研究製品市場分析と洞察
がんやさまざまな自己免疫疾患の罹患率と発症率の増加により、市場の需要が高まっています。より良い医療サービスを求める医療費の増加も、市場の成長に貢献しています。主要な市場プレーヤーは、この重要な時期にさまざまなサービスの立ち上げと承認に重点を置いています。さらに、製薬研究開発とライフサイエンス研究への投資の増加も、エキソソーム研究製品のテストに対する需要の高まりに貢献しています。
ヨーロッパのエクソソーム研究製品市場は、市場プレーヤーの増加と高度なサービスの利用可能性により、予測年度に成長すると予想されています。これに伴い、メーカーは市場で新しいサービスを開始するための研究開発活動に取り組んでいます。
しかし、エクソソームの開発と製造に関するゴールドスタンダードプロトコルが欠如しているため、予測期間中のヨーロッパのエクソソーム研究製品市場の成長が妨げられる可能性があります。
エクソソーム技術のさらなる進歩により、市場に治療を強化する機会が生まれることが期待されます。
しかし、エクソソーム研究製品に伴う副作用や製品発売に伴う承認の遅れが、市場の成長を妨げる可能性があります。
データブリッジマーケットリサーチは、ヨーロッパのエクソソーム研究製品市場は、予測期間中に33.6％のCAGRで成長し、2030年までに5,15,818.76千米ドルに達すると予測しています。診断および治療におけるエクソソーム研究製品の使用が増加しているため、製品は市場で最大のタイプセグメントを占めています。
|
レポートメトリック |
詳細 |
|
予測期間 |
2023年から2030年 |
|
基準年 |
2022 |
|
歴史的な年 |
2021 (2015～2020年にカスタマイズ可能) |
|
定量単位 |
売上高は千米ドル、販売数量は個数、価格は米ドル |
|
対象セグメント |
製品別（機器および消耗品）、適応症別（がんおよび非がん）、用途別（治療薬および診断薬）、エンドユーザー別（病院、臨床検査研究所、研究センター、製薬およびバイオテクノロジー企業、学術機関、その他）、流通チャネル別（サードパーティの販売代理店、オンライン、直接入札） |
|
対象国 |
ドイツ、フランス、イギリス、イタリア、スペイン、オランダ、ロシア、スイス、トルコ、ベルギー、その他のヨーロッパ諸国 |
|
対象となる市場プレーヤー |
Hologic Inc.、Luminex Corporation、Thermo Fisher Scientific、Agilent Technologies, Inc.、Cell Guidance Systems LLC、QIAGEN、FUJIFILM Irvine Scientific（富士フイルムホールディングス株式会社の子会社）、CUSABIO TECHNOLOGY LLC、Norgen Biotek Corp.、Miltenyi Biotec、AMSBIO、ExoDx（Bio-Techneが買収）、Creative Bioarray、Novus Biologicals、Beckman Coulter, Inc.、JSR Micro NV、日立製作所、INOVIQ、Audubon Bioscienceなど |
ヨーロッパのエクソソーム研究製品市場の定義
エクソソームは、エンドソームで構成される細胞由来の細胞外小胞の特定のクラスであり、通常、直径は 30 ～ 150 nm で、最も小さいタイプの細胞外小胞です。脂質二重層で保護されたエクソソームは、元の細胞に由来する複雑な貨物を内包して細胞外環境に押し出されます。貨物に含まれる内容物は、タンパク質、脂質、メッセンジャーリボ核酸 (mRNA)、ミクロソームリボ核酸 (miRNA)、およびデオキシリボ核酸 (DNA) です。
エクソソームは、自己免疫疾患などのさまざまな慢性疾患の治療に利用されています。エクソソーム療法は、薬物送達、腫瘍免疫療法、診断バイオマーカーに広く使用されています。エクソソームは、その小さなサイズ、天然の性質、および生物学的障壁を越える能力により、薬物キャリアとして使用されています。
ヨーロッパのエクソソーム研究製品市場の動向
このセクションでは、市場の推進要因、利点、機会、制約、課題について理解します。これらについては、以下で詳しく説明します。
ドライバー
- 癌、慢性炎症、自己免疫疾患、ライム病、その他の慢性変性疾患の罹患率の増加
WHOによると、がんは世界的に死亡原因のトップであり、2020年には約1,000万人が亡くなりました。インドでは、2020年の男性のがん患者数は約679,421人、女性は約712,758人でした。2021年の米国の新規がん症例数と死亡者数は約190万人、がんによる死亡者は608,570人でした。このように、がんの発生率は研究者にますます多くの研究を促しており、バイオマーカーはがんの診断に役立ちます。したがって、市場の成長が加速しています。
したがって、結論として、心血管疾患、神経疾患、その他のさまざまな慢性疾患などの慢性疾患の増加により、さまざまな医薬品の需要が増加し、今後数年間でヨーロッパのエクソソーム研究製品市場の成長を促進することになります。
- 医薬品研究開発およびライフサイエンス研究への投資の増加
学術研究機関、製薬およびバイオテクノロジー企業、病院、臨床検査研究所が市場の主なエンドユーザーです。近年、エクソソーム研究の需要が高まっています。これは、エクソソームが病気の検出に潜在的であり、細胞間メッセンジャーとしての役割が新たに出現しているためです。これが多くの学術研究者の関心を集め、市場の成長につながっています。2022年の製薬研究開発費の動向によると、現在、世界中で6,000以上の項目が臨床試験で検査されており、2016年と比較して68％増加しています。
市場プレーヤーが研究開発活動に絶えず取り組んでいるため、ヨーロッパのエクソソーム研究製品市場では、より多くのハイブリッドおよび天然エクソソームが導入されています。これにより、病院や診断センターでの癌や自己免疫疾患の治療のためのエクソソーム治療薬の需要が高まります。したがって、研究開発活動の進歩と製薬部門への投資の増加が、市場全体の成長を促進すると予想されます。
拘束
- エクソソームの開発と生産のためのゴールドスタンダードプロトコルの欠如
エクソソームの分野はまだ初期段階にあり、これまでのところゴールドスタンダードは開発されていません。そのため、専門家はためらうことなく市場の新しい手順と方法論を採用しています。研究者がエクソソームの製造中にミスを犯すだけでなく、科学者はエクソソームの研究開発と製造活動においてさまざまな課題に直面しています。
エクソソームの認証と安全性の欠如は、安全プロトコルと天然およびハイブリッドエクソソームの生産を妨げることになります。したがって、エクソソームの開発における標準プロトコルの欠如とエクソソームの分離に対する認証要件の欠如は、エクソソーム研究製品市場の成長を抑制すると予想されます。
機会
-
エンドユーザーの間で専門的なテストサービスの需要が増加
エクソソームは、高度な RNA とタンパク質のカーゴを含む小さな (30～150 nm) 小胞で、体外および体内のすべての細胞から絶えず分泌されます。エクソソームは、細胞間コミュニケーションやシグナル伝達など、人体内の興味深い機能により、研究に変化をもたらしています。
今後、液体クロマトグラフィー質量分析、RNA シーケンシング、湿式化学、遺伝子発現、その他のさまざまなテスト サービスなどの専門的なテスト サービスの利用の増加が、エキソソーム研究製品市場の成長の原動力となり、これらのテスト サービスが正確な結果を正確に提供できることで、エンド ユーザーの間で需要が高まっています。
チャレンジ
- エクソソーム研究製品に関連する副作用
While all medical treatments have benefits and risks, unapproved exosome products expose patients to potential risks without a clear benefit. These products may potentially treat many medical conditions and diseases, but further research is needed to know whether the products have any benefit or are safe to use. The side effects may include injection site reaction, failure of the cells to work as expected, growth of tumors, infections, and the potential for contamination of the product, the ability of cells to move from placement sites and multiply or change into inappropriate cell types
Henceforth, the various side effects of exosome research products for their diagnosis safety, cost, and convenience issues are expected to challenge the Europe exosome research products market.
Recent Developments
- In July 2022, Aethlon Medical, Inc., a medical therapy company focused on developing products for the diagnosis and treatment of cancer and life-threatening infectious diseases, announced that the US Food and Drug Administration (FDA) had approved a protocol amendment for an ongoing clinical trial of Aethlon Hemopurifier for patients with severe COVID-19
- In April 2020, ExoDX launched the ExoDx Prostate Test Home Collection Kit for patients concerned about prostate health. The home collection kit provides an immediate and cost-effective solution that enables a telemedicine/telehealth option for physicians and their patients who share the frustration, anxiety, and fear of the advanced prostate cancer patient
Europe Exosome Research Products Market Scope
Europe exosome research products market is segmented into five notable segments such as product, indication, application, end user, and distribution channel. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.
EUROPE EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT
- INSTRUMENTS
- Consumables
On the basis of product, the Europe exosome research products market is segmented into instruments and consumables.
EUROPE EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION
- CANCER
- NON CANCER
On the basis of indication, the Europe exosome research products market is segmented into cancer and non-cancer.
EUROPE EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION
- THERAPEUTICS
- DIAGNOSTICS
On the basis of application, the Europe exosome research products market is segmented into therapeutics and diagnostics.
EUROPE EXOSOME RESEARCH PRODUCTS MARKET, BY END USERS
- HOSPITALS
- CLINICAL TESTING LABORATORIES
- RESEARCH CENTERS
- PHARMACEUTICAL AND BIOTECHNOLOGY COMPANY
- ACADEMIC INSTITUTES
- OTHERS
On the basis of end users, the Europe exosome research products market is segmented into hospitals, clinical testing laboratory, research centers, pharmaceutical and biotechnology company, academic institutes, and others.
EUROPE EXOSOME RESEARCH PRODUCTS MARKET, BY DISTRIBUTION CHANNEL
- THIRD PARTY DISTRIBUTORS
- ONLINE
- 直接入札
流通チャネルに基づいて、ヨーロッパのエクソソーム研究製品市場は、サードパーティの販売代理店、オンライン、直接入札に分類されます。
ヨーロッパのエクソソーム研究製品市場地域分析/洞察
ヨーロッパのエクソソーム研究製品市場は、製品、適応症、用途、エンドユーザー、流通チャネルなど、5 つの主要なセグメントに分類されています。
この市場レポートで取り上げられている国は、フランス、英国、イタリア、スペイン、オランダ、ロシア、スイス、トルコ、ベルギー、およびその他のヨーロッパ諸国です。
エクソソーム研究製品の生産増加、新興市場からの需要増加、ヘルスケア産業の拡大により、ドイツはヨーロッパ地域で優位に立つと予想されています。
レポートの国別セクションでは、市場の現在および将来の傾向に影響を与える個々の市場影響要因と国内規制の変更も提供しています。新規販売、交換販売、国の人口統計、規制行為、輸出入関税などのデータ ポイントは、個々の国の市場シナリオを予測するために使用される主要な指標の一部です。また、国別データの予測分析を提供する際には、ヨーロッパ ブランドの存在と可用性、地元および国内ブランドとの競争が激しいか少ないために直面する課題、および販売チャネルの影響も考慮されます。
競争環境と欧州のエクソソーム研究製品の市場シェア分析
ヨーロッパのエクソソーム研究製品市場の競争環境は、競合他社の詳細を提供します。詳細には、会社概要、会社の財務状況、収益、市場の可能性、研究開発への投資、新しい市場への取り組み、生産拠点と施設、会社の強みと弱み、製品の発売、製品の承認、製品の幅と広さ、アプリケーションの優位性、および技術ライフライン曲線が含まれます。上記のデータ ポイントは、ヨーロッパのエクソソーム研究製品市場への会社の重点にのみ関連しています。
ヨーロッパのエクソソーム研究製品市場で活動している主要企業には、Hologic Inc.、Luminex Corporation、Thermo Fisher Scientific、Agilent Technologies, Inc.、Cell Guidance Systems LLC、QIAGEN、FUJIFILM Irvine Scientific（富士フイルムホールディングス株式会社の子会社）、CUSABIO TECHNOLOGY LLC、Norgen Biotek Corp.、Miltenyi Biotec、AMSBIO、ExoDx（Bio-Techneが買収）、Creative Bioarray、Novus Biologicals、Beckman Coulter, Inc.、JSR Micro NV、日立製作所、INOVIQ、Audubon Bioscienceなどがあります。
SKU-
世界初のマーケットインテリジェンスクラウドに関するレポートにオンラインでアクセスする
- インタラクティブなデータ分析ダッシュボード
- 成長の可能性が高い機会のための企業分析ダッシュボード
- カスタマイズとクエリのためのリサーチアナリストアクセス
- インタラクティブなダッシュボードによる競合分析
- 最新ニュース、更新情報、トレンド分析
- 包括的な競合追跡のためのベンチマーク分析のパワーを活用
目次
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF THE EUROPE EXOSOME RESEARCH PRODUCTS MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 PRODUCT LIFELINE CURVE
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.9 DBMR MARKET POSITION GRID
2.1 MARKET APPLICATION COVERAGE GRID
2.11 VENDOR SHARE ANALYSIS
2.12 SECONDARY SOURCES
2.13 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PESTEL ANALYSIS
4.2 PORTER'S FIVE FORCES MODEL
4.3 SUPPLY CHAIN ANALYSIS
4.4 VALUE CHAIN ANALYSIS
4.5 BUSINESS STRATEGY EXCELLENCE
4.6 CASE STUDIES
4.7 STRENGTH OF PRODUCT PORTFOLIO
4.8 TECHNOLOGICAL TRENDS
4.9 PRICING ANALYSIS
5 INDUSTRY INSIGHTS
6 EUROPE EXOSOME RESEARCH PRODUCTS MARKET, REGULATIONS
7 MARKET OVERVIEW
7.1 DRIVERS
7.1.1 GROWING PREVALENCE OF CANCER, CHRONIC INFLAMMATION, AUTOIMMUNE DISEASE, LYME DISEASE, AND OTHER CHRONIC DEGENERATIVE DISEASES
7.1.2 INCREASING INVESTMENTS IN PHARMACEUTICAL R&D AND LIFE SCIENCES RESEARCH
7.1.3 AVAILABILITY OF VARIOUS EXOSOME ISOLATION AND PURIFICATION TECHNIQUES AND PROGRESSING THERAPEUTIC VALUE OF EXOSOME
7.2 RESTRAINTS
7.2.1 LACK OF GOLD STANDARD PROTOCOLS FOR THE DEVELOPMENT AND PRODUCTION OF EXOSOMES
7.2.2 THE SHORTAGE OF SKILLED PROFESSIONALS REQUIRED FOR THE ISOLATION OF EXOSOME
7.3 OPPORTUNITIES
7.3.1 RISING DEMAND FOR SPECIALIZED TESTING SERVICES AMONG END USERS.
7.3.2 INCREASING ADVANCEMENT IN EXOSOME TECHNOLOGY
7.3.3 STRATEGIC INITIATIVES BY MARKET PLAYERS
7.4 CHALLENGES
7.4.1 SIDE EFFECTS ASSOCIATED WITH EXOSOME RESEARCH PRODUCTS
7.4.2 LATE APPROVAL ASSOCIATED WITH PRODUCT LAUNCHES
8 EUROPE EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT
8.1 OVERVIEW
8.2 CONSUMABLES
8.2.1 KITS AND REAGENTS
8.2.1.1 EXOSOME BIOMARKER KITS
8.2.1.2 EXOSOME ISOLATION KITS
8.2.1.3 EXOSOME PURIFICATION KITS
8.2.1.4 EXOSOME QUANTITATIVE KITS
8.2.1.5 EXOSOME DETECTION KITS
8.2.1.6 OTHERS
8.2.2 EXOSOME STANDARDS
8.2.3 EXOSOME ANTIBODIES
8.2.4 CELL LINES
8.2.5 IMMUNOPLATES
8.2.6 IMMUNOBEADS
8.2.7 BIOFLUIDS
8.2.8 OTHERS
8.3 INSTRUMENTS
8.3.1 BENCHTOP
8.3.2 STANDALONE
9 EUROPE EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION
9.1 OVERVIEW
9.2 CANCER
9.2.1 LUNG CANCER
9.2.2 BREAST CANCER
9.2.3 COLORECTAL CANCER
9.2.4 PROSTATE CANCER
9.2.5 OTHER CANCER
9.3 NON-CANCER
9.3.1 CARDIOVASCULAR DISEASE
9.3.2 NEURODEGENERATIVE DISEASE
9.3.3 INFECTIOUS DISEASE
9.3.4 OTHERS
10 EUROPE EXOSOME RESEARCH PRODUCTS MARKET: BY APPLICATION
10.1 OVERVIEW
10.2 THERAPEUTICS
10.3 CONSUMABLES
10.4 INSTRUMENTS
10.5 DIAGNOSIS
10.6 CONSUMABLES
10.7 INSTRUMENTS
11 EUROPE EXOSOME RESEARCH PRODUCTS MARKET, BY END USER
11.1 OVERVIEW
11.2 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANY
11.3 CONSUMABLES
11.4 INSTRUMENTS
11.5 RESEARCH CENTRES
11.6 CONSUMABLES
11.7 INSTRUMENTS
11.8 ACADEMIC INSTITUTES
11.9 CONSUMABLES
11.1 INSTRUMENTS
11.11 CLINICAL TESTING LABORATORY
11.12 CONSUMABLES
11.13 INSTRUMENTS
11.14 HOSPITALS
11.15 CONSUMABLES
11.16 INSTRUMENTS
11.17 OTHERS
12 EUROPE EXOSOME RESEARCH PRODUCTS MARKET, BY DISTRIBUTION CHANNEL
12.1 OVERVIEW
12.2 THIRD PARTY DISTRIBUTORS
12.3 DIRECT SALES
12.4 ONLINE
13 EUROPE EXOSOME RESEARCH PRODUCTS MARKET, BY REGION
13.1 EUROPE
13.1.1 GERMANY
13.1.2 U.K.
13.1.3 FRANCE
13.1.4 ITALY
13.1.5 SPAIN
13.1.6 RUSSIA
13.1.7 SWITZERLAND
13.1.8 NETHERLANDS
13.1.9 TURKEY
13.1.10 SWEDEN
13.1.11 POLAND
13.1.12 NORWAY
13.1.13 BELGIUM
13.1.14 FINLAND
13.1.15 DENMARK
13.1.16 REST OF EUROPE
14 EUROPE EXOSOME RESEARCH PRODUCTS MARKET, COMPANY LANDSCAPE
14.1 COMPANY SHARE ANALYSIS: EUROPE
15 SWOT ANALYSIS
16 COMPANY PROFILE
16.1 THERMO FISHER SCIENTIFIC INC.
16.1.1 COMPANY SNAPSHOT
16.1.2 REVENUE ANALYSIS
16.1.3 COMPANY SHARE ANALYSIS
16.1.4 PRODUCT PORTFOLIO
16.1.5 RECENT DEVELOPMENT
16.2 EXODX (ACQUIRED BY BIO-TECHNE)
16.2.1 COMPANY SNAPSHOT
16.2.2 REVENUE ANALYSIS
16.2.3 COMPANY SHARE ANALYSIS
16.2.4 PRODUCT PORTFOLIO
16.2.5 RECENT DEVELOPMENT
16.3 MILTENYI BIOTEC
16.3.1 COMPANY SNAPSHOT
16.3.2 COMPANY SHARE ANALYSIS
16.3.3 PRODUCT PORTFOLIO
16.3.4 RECENT DEVELOPMENTS
16.4 LUMINEX CORPORATION
16.4.1 COMPANY SNAPSHOT
16.4.2 PRODUCT PORTFOLIO
16.4.3 RECENT DEVELOPMENT
16.5 HOLOGIC, INC.
16.5.1 COMPANY SNAPSHOT
16.5.2 REVENUE ANALYSIS
16.5.3 COMPANY SHARE ANALYSIS
16.5.4 PRODUCT PORTFOLIO
16.5.5 RECENT DEVELOPMENTS
16.6 AETHLON MEDICAL, INC. (2022)
16.6.1 COMPANY SNAPSHOT
16.6.2 PRODUCT PORTFOLIO
16.6.3 RECENT DEVELOPMENTS
16.7 AGILENT TECHNOLOGIES, INC.
16.7.1 COMPANY SNAPSHOT
16.7.2 REVENUE ANALYSIS
16.7.3 PRODUCT PORTFOLIO
16.7.4 RECENT DEVELOPMENT
16.8 AMSBI0
16.8.1 COMPANY SNAPSHOT
16.8.2 PRODUCT PORTFOLIO
16.8.3 RECENT DEVELOPMENT
16.9 AUDUBON BIOSCIENCE.
16.9.1 COMPANY SNAPSHOT
16.9.2 PRODUCT PORTFOLIO
16.9.3 RECENT DEVELOPMENT
16.1 BECKMAN COULTER, INC
16.10.1 COMPANY SNAPSHOT
16.10.2 PRODUCT PORTFOLIO
16.10.3 RECENT DEVELOPMENT
16.11 BIOVISION INC. (ACQUIRED BY ABCAM PLC)
16.11.1 COMPANY SNAPSHOT
16.11.2 REVENUE ANALYSIS
16.11.3 COMPANY SHARE ANALYSIS
16.11.4 PRODUCT PORTFOLIO
16.11.5 RECENT DEVELOPMENT
16.12 CELL GUIDANCE SYSTEMS LLC
16.12.1 COMPANY SNAPSHOT
16.12.2 PRODUCT PORTFOLIO
16.12.3 RECENT DEVELOPMENTS
16.13 CREATIVE BIOARRAY
16.13.1 COMPANY SNAPSHOT
16.13.2 PRODUCT PORTFOLIO
16.13.3 RECENT DEVELOPMENT
16.14 CUSABIO TECHNOLOGY LLC
16.14.1 COMPANY SNAPSHOT
16.14.2 PRODUCT PORTFOLIO
16.14.3 RECENT DEVELOPMENTS
16.15 FUJIFILM IRVINE SCIENTIFIC (A SUBSIDIARY OF FUJIFILM HOLDINGS CORPORATION
16.15.1 COMPANY SNAPSHOT
16.15.2 REVENUE ANALYSIS
16.15.3 PRODUCT PORTFOLIO
16.15.4 RECENT DEVELOPMENT
16.16 HBMLS (ACQUIRED BY LONZA)
16.16.1 COMPANY SNAPSHOT
16.16.2 REVENUE ANALYSIS
16.16.3 PRODUCT PORTFOLIO
16.16.4 RECENT DEVELOPMENT
16.17 HITACHI, LTD.
16.17.1 COMPANY SNAPSHOT
16.17.2 REVENUE ANALYSIS
16.17.3 PRODUCT PORTFOLIO
16.17.4 RECENT DEVELOPMENT
16.18 INOVIQ
16.18.1 COMPANY SNAPSHOT
16.18.2 REVENUE ANALYSIS
16.18.3 PRODUCT PORTFOLIO
16.18.4 RECENT DEVELOPMENT
16.19 JSR MICRO NV
16.19.1 COMPANY SNAPSHOT
16.19.2 PRODUCT PORTFOLIO
16.19.3 RECENT DEVELOPMENT
16.2 MICROGENTAS
16.20.1 COMPANY SNAPSHOT
16.20.2 PRODUCT PORTFOLIO
16.20.3 RECENT DEVELOPMENTS
16.21 NANOSOMIX
16.21.1 COMPANY SNAPSHOT
16.21.2 PRODUCT PORTFOLIO
16.21.3 RECENT DEVELOPMENT
16.22 NEXOSOME-ONCOLOGY
16.22.1 COMPANY SNAPSHOT
16.22.2 PRODUCT PORTFOLIO
16.22.3 RECENT DEVELOPMENTS
16.23 NORGEN BIOTEK CORP.
16.23.1 COMPANY SNAPSHOT
16.23.2 PRODUCT PORTFOLIO
16.23.3 RECENT DEVELOPMENTS
16.24 NOVUS BIOLOGICALS
16.24.1 COMPANY SNAPSHOT
16.24.2 PRODUCT PORTFOLIO
16.24.3 RECENT DEVELOPMENT
16.25 PROTEOGENEX
16.25.1 COMPANY SNAPSHOT
16.25.2 PRODUCT PORTFOLIO
16.25.3 RECENT DEVELOPMENT
16.26 QIAGEN
16.26.1 COMPANY SNAPSHOT
16.26.2 REVENUE ANALYSIS
16.26.3 PRODUCT PORTFOLIO
16.26.4 RECENT DEVELOPMENT
16.27 ROOSTERBIO, INC.
16.27.1 COMPANY SNAPSHOT
16.27.2 PRODUCT PORTFOLIO
16.27.3 RECENT DEVELOPMENTS
16.28 SYSTEM BIOSCIENCES, LLC.
16.28.1 COMPANY SNAPSHOT
16.28.2 PRODUCT PORTFOLIO
16.28.3 RECENT DEVELOPMENT
17 QUESTIONNAIRE
18 RELATED REPORTS
表のリスト
TABLE 1 EUROPE EXOSOME RESEARCH PRODUCTS MARKET, PRICING ANALYSIS
TABLE 2 EUROPE EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT , 2021-2030 (USD THOUSAND)
TABLE 3 EUROPE CONSUMABLES IN EXOSOME RESEARCH PRODUCTS MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 4 EUROPE CONSUMABLES IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 5 EUROPE KITS AND REAGENTS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 6 EUROPE INSTRUMENTS IN EXOSOME RESEARCH PRODUCTS MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 7 EUROPE INSTRUMENTS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 8 EUROPE EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND)
TABLE 9 EUROPE CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 10 EUROPE CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND)
TABLE 11 EUROPE NON-CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 12 EUROPE NON-CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND)
TABLE 13 EUROPE EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 14 EUROPE THERAPEUTICS IN EXOSOME RESEARCH PRODUCTS MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 15 EUROPE THERAPEUTICS IN EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 16 EUROPE DIAGNOSIS IN EXOSOME RESEARCH PRODUCTS MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 17 EUROPE DIAGNOSIS IN EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 18 EUROPE EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 19 EUROPE PHARMACEUTICAL AND BIOTECHNOLOGY COMPANY IN EXOSOME RESEARCH PRODUCTS MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 20 EUROPE PHARMACEUTICAL & BIOTECHNOLOGY COMPANY IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER 2021-2030 (USD THOUSAND)
TABLE 21 EUROPE RESEARCH CENTERS IN EXOSOME RESEARCH PRODUCTS MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 22 EUROPE RESEARCH CENTERS IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER 2021-2030 (USD THOUSAND)
TABLE 23 EUROPE ACADEMIC INSTITUTES IN EXOSOME RESEARCH PRODUCTS MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 24 EUROPE ACADEMIC INSTITUTES IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER 2021-2030 (USD THOUSAND)
TABLE 25 EUROPE CLINICAL TESTING LABORATORY IN EXOSOME RESEARCH PRODUCTS MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 26 EUROPE CLINICAL TESTING LABORATORY IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 27 EUROPE HOSPITALS IN EXOSOME RESEARCH PRODUCTS MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 28 EUROPE HOSPITALS IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER 2021-2030 (USD THOUSAND)
TABLE 29 EUROPE OTHERS IN EXOSOME RESEARCH PRODUCTS MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 30 EUROPE EXOSOME RESEARCH PRODUCTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND)
TABLE 31 EUROPE THIRD PARTY DISTRIBUTORS IN EXOSOME RESEARCH PRODUCTS MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 32 EUROPE DIRECT SALES IN EXOSOME RESEARCH PRODUCTS MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 33 EUROPE ONLINE IN EXOSOME RESEARCH PRODUCTS MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 34 EUROPE EXOSOME RESEARCH PRODUCTS MARKET, BY COUNTRY, 2021-2030 (USD THOUSAND)
TABLE 35 EUROPE EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 36 EUROPE CONSUMABLES IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 37 EUROPE KITS & REAGENTS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 38 EUROPE INSTRUMENTS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 39 EUROPE EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND)
TABLE 40 EUROPE CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND)
TABLE 41 EUROPE NON-CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND)
TABLE 42 EUROPE EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 43 EUROPE THERAPEUTICS IN EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 44 EUROPE DIAGNOSIS IN EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 45 EUROPE EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 46 EUROPE PHARMACEUTICAL & BIOTECHNOLOGY COMPANY IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 47 EUROPE RESEARCH CENTERS IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 48 EUROPE ACADEMIC INSTITUTES IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 49 EUROPE CLINICAL TESTING LABORATORY IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 50 EUROPE HOSPITALS IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 51 EUROPE EXOSOME RESEARCH PRODUCTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND)
TABLE 52 GERMANY EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 53 GERMANY CONSUMABLES IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 54 GERMANY KITS & REAGENTS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 55 GERMANY INSTRUMENTS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 56 GERMANY EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND)
TABLE 57 GERMANY CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND)
TABLE 58 GERMANY NON-CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND)
TABLE 59 GERMANY EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 60 GERMANY THERAPEUTICS IN EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 61 GERMANY DIAGNOSIS IN EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 62 GERMANY EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 63 GERMANY PHARMACEUTICAL & BIOTECHNOLOGY COMPANY IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 64 GERMANY RESEARCH CENTERS IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 65 GERMANY ACADEMIC INSTITUTES IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 66 GERMANY CLINICAL TESTING LABORATORY IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 67 GERMANY HOSPITALS IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 68 GERMANY EXOSOME RESEARCH PRODUCTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND)
TABLE 69 U.K. EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 70 U.K. CONSUMABLES IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 71 U.K. KITS & REAGENTS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 72 U.K. INSTRUMENTS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 73 U.K. EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND)
TABLE 74 U.K. CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND)
TABLE 75 U.K. NON-CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND)
TABLE 76 U.K. EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 77 U.K. THERAPEUTICS IN EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 78 U.K. DIAGNOSIS IN EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 79 U.K. EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 80 U.K. PHARMACEUTICAL & BIOTECHNOLOGY COMPANY IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 81 U.K. RESEARCH CENTERS IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 82 U.K. ACADEMIC INSTITUTES IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 83 U.K. CLINICAL TESTING LABORATORY IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 84 U.K. HOSPITALS IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 85 U.K. EXOSOME RESEARCH PRODUCTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND)
TABLE 86 FRANCE EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 87 FRANCE CONSUMABLES IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 88 FRANCE KITS & REAGENTS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 89 FRANCE INSTRUMENTS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 90 FRANCE EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND)
TABLE 91 FRANCE CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND)
TABLE 92 FRANCE NON-CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND)
TABLE 93 FRANCE EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 94 FRANCE THERAPEUTICS IN EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 95 FRANCE DIAGNOSIS IN EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 96 FRANCE EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 97 FRANCE PHARMACEUTICAL & BIOTECHNOLOGY COMPANY IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 98 FRANCE RESEARCH CENTERS IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 99 FRANCE ACADEMIC INSTITUTES IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 100 FRANCE CLINICAL TESTING LABORATORY IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 101 FRANCE HOSPITALS IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 102 FRANCE EXOSOME RESEARCH PRODUCTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND)
TABLE 103 ITALY EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 104 ITALY CONSUMABLES IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 105 ITALY KITS & REAGENTS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 106 ITALY INSTRUMENTS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 107 ITALY EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND)
TABLE 108 ITALY CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND)
TABLE 109 ITALY NON-CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND)
TABLE 110 ITALY EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 111 ITALY THERAPEUTICS IN EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 112 ITALY DIAGNOSIS IN EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 113 ITALY EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 114 ITALY PHARMACEUTICAL & BIOTECHNOLOGY COMPANY IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 115 ITALY RESEARCH CENTERS IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 116 ITALY ACADEMIC INSTITUTES IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 117 ITALY CLINICAL TESTING LABORATORY IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 118 ITALY HOSPITALS IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 119 ITALY EXOSOME RESEARCH PRODUCTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND)
TABLE 120 SPAIN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 121 SPAIN CONSUMABLES IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 122 SPAIN KITS & REAGENTS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 123 SPAIN INSTRUMENTS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 124 SPAIN EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND)
TABLE 125 SPAIN CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND)
TABLE 126 SPAIN NON-CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND)
TABLE 127 SPAIN EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 128 SPAIN THERAPEUTICS IN EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 129 SPAIN DIAGNOSIS IN EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 130 SPAIN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 131 SPAIN PHARMACEUTICAL & BIOTECHNOLOGY COMPANY IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 132 SPAIN RESEARCH CENTERS IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 133 SPAIN ACADEMIC INSTITUTES IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 134 SPAIN CLINICAL TESTING LABORATORY IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 135 SPAIN HOSPITALS IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 136 SPAIN EXOSOME RESEARCH PRODUCTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND)
TABLE 137 RUSSIA EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 138 RUSSIA CONSUMABLES IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 139 RUSSIA KITS & REAGENTS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 140 RUSSIA INSTRUMENTS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 141 RUSSIA EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND)
TABLE 142 RUSSIA CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND)
TABLE 143 RUSSIA NON-CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND)
TABLE 144 RUSSIA EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 145 RUSSIA THERAPEUTICS IN EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 146 RUSSIA DIAGNOSIS IN EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 147 RUSSIA EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 148 RUSSIA PHARMACEUTICAL & BIOTECHNOLOGY COMPANY IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 149 RUSSIA RESEARCH CENTERS IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 150 RUSSIA ACADEMIC INSTITUTES IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 151 RUSSIA CLINICAL TESTING LABORATORY IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 152 RUSSIA HOSPITALS IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 153 RUSSIA EXOSOME RESEARCH PRODUCTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND)
TABLE 154 SWITZERLAND EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 155 SWITZERLAND CONSUMABLES IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 156 SWITZERLAND KITS & REAGENTS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 157 SWITZERLAND INSTRUMENTS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 158 SWITZERLAND EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND)
TABLE 159 SWITZERLAND CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND)
TABLE 160 SWITZERLAND NON-CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND)
TABLE 161 SWITZERLAND EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 162 SWITZERLAND THERAPEUTICS IN EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 163 SWITZERLAND DIAGNOSIS IN EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 164 SWITZERLAND EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 165 SWITZERLAND PHARMACEUTICAL & BIOTECHNOLOGY COMPANY IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 166 SWITZERLAND RESEARCH CENTERS IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 167 SWITZERLAND ACADEMIC INSTITUTES IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 168 SWITZERLAND CLINICAL TESTING LABORATORY IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 169 SWITZERLAND HOSPITALS IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 170 SWITZERLAND EXOSOME RESEARCH PRODUCTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND)
TABLE 171 NETHERLANDS EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 172 NETHERLANDS CONSUMABLES IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 173 NETHERLANDS KITS & REAGENTS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 174 NETHERLANDS INSTRUMENTS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 175 NETHERLANDS EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND)
TABLE 176 NETHERLANDS CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND)
TABLE 177 NETHERLANDS NON-CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND)
TABLE 178 NETHERLANDS EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 179 NETHERLANDS THERAPEUTICS IN EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 180 NETHERLANDS DIAGNOSIS IN EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 181 NETHERLANDS EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 182 NETHERLANDS PHARMACEUTICAL & BIOTECHNOLOGY COMPANY IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 183 NETHERLANDS RESEARCH CENTERS IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 184 NETHERLANDS ACADEMIC INSTITUTES IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 185 NETHERLANDS CLINICAL TESTING LABORATORY IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 186 NETHERLANDS HOSPITALS IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 187 NETHERLANDS EXOSOME RESEARCH PRODUCTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND)
TABLE 188 TURKEY EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 189 TURKEY CONSUMABLES IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 190 TURKEY KITS & REAGENTS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 191 TURKEY INSTRUMENTS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 192 TURKEY EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND)
TABLE 193 TURKEY CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND)
TABLE 194 TURKEY NON-CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND)
TABLE 195 TURKEY EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 196 TURKEY THERAPEUTICS IN EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 197 TURKEY DIAGNOSIS IN EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 198 TURKEY EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 199 TURKEY PHARMACEUTICAL & BIOTECHNOLOGY COMPANY IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 200 TURKEY RESEARCH CENTERS IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 201 TURKEY ACADEMIC INSTITUTES IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 202 TURKEY CLINICAL TESTING LABORATORY IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 203 TURKEY HOSPITALS IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 204 TURKEY EXOSOME RESEARCH PRODUCTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND)
TABLE 205 SWEDEN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 206 SWEDEN CONSUMABLES IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 207 SWEDEN KITS & REAGENTS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 208 SWEDEN INSTRUMENTS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 209 SWEDEN EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND)
TABLE 210 SWEDEN CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND)
TABLE 211 SWEDEN NON-CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND)
TABLE 212 SWEDEN EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 213 SWEDEN THERAPEUTICS IN EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 214 SWEDEN DIAGNOSIS IN EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 215 SWEDEN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 216 SWEDEN PHARMACEUTICAL & BIOTECHNOLOGY COMPANY IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 217 SWEDEN RESEARCH CENTERS IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 218 SWEDEN ACADEMIC INSTITUTES IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 219 SWEDEN CLINICAL TESTING LABORATORY IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 220 SWEDEN HOSPITALS IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 221 SWEDEN EXOSOME RESEARCH PRODUCTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND)
TABLE 222 POLAND EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 223 POLAND CONSUMABLES IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 224 POLAND KITS & REAGENTS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 225 POLAND INSTRUMENTS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 226 POLAND EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND)
TABLE 227 POLAND CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND)
TABLE 228 POLAND NON-CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND)
TABLE 229 POLAND EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 230 POLAND THERAPEUTICS IN EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 231 POLAND DIAGNOSIS IN EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 232 POLAND EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 233 POLAND PHARMACEUTICAL & BIOTECHNOLOGY COMPANY IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 234 POLAND RESEARCH CENTERS IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 235 POLAND ACADEMIC INSTITUTES IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 236 POLAND CLINICAL TESTING LABORATORY IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 237 POLAND HOSPITALS IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 238 POLAND EXOSOME RESEARCH PRODUCTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND)
TABLE 239 NORWAY EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 240 NORWAY CONSUMABLES IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 241 NORWAY KITS & REAGENTS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 242 NORWAY INSTRUMENTS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 243 NORWAY EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND)
TABLE 244 NORWAY CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND)
TABLE 245 NORWAY NON-CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND)
TABLE 246 NORWAY EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 247 NORWAY THERAPEUTICS IN EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 248 NORWAY DIAGNOSIS IN EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 249 NORWAY EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 250 NORWAY PHARMACEUTICAL & BIOTECHNOLOGY COMPANY IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 251 NORWAY RESEARCH CENTERS IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 252 NORWAY ACADEMIC INSTITUTES IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 253 NORWAY CLINICAL TESTING LABORATORY IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 254 NORWAY HOSPITALS IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 255 NORWAY EXOSOME RESEARCH PRODUCTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND)
TABLE 256 BELGIUM EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 257 BELGIUM CONSUMABLES IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 258 BELGIUM KITS & REAGENTS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 259 BELGIUM INSTRUMENTS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 260 BELGIUM EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND)
TABLE 261 BELGIUM CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND)
TABLE 262 BELGIUM NON-CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND)
TABLE 263 BELGIUM EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 264 BELGIUM THERAPEUTICS IN EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 265 BELGIUM DIAGNOSIS IN EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 266 BELGIUM EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 267 BELGIUM PHARMACEUTICAL & BIOTECHNOLOGY COMPANY IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 268 BELGIUM RESEARCH CENTERS IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 269 BELGIUM ACADEMIC INSTITUTES IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 270 BELGIUM CLINICAL TESTING LABORATORY IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 271 BELGIUM HOSPITALS IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 272 BELGIUM EXOSOME RESEARCH PRODUCTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND)
TABLE 273 FINLAND EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 274 FINLAND CONSUMABLES IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 275 FINLAND KITS & REAGENTS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 276 FINLAND INSTRUMENTS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 277 FINLAND EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND)
TABLE 278 FINLAND CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND)
TABLE 279 FINLAND NON-CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND)
TABLE 280 FINLAND EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 281 FINLAND THERAPEUTICS IN EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 282 FINLAND DIAGNOSIS IN EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 283 FINLAND EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 284 FINLAND PHARMACEUTICAL & BIOTECHNOLOGY COMPANY IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 285 FINLAND RESEARCH CENTERS IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 286 FINLAND ACADEMIC INSTITUTES IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 287 FINLAND CLINICAL TESTING LABORATORY IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 288 FINLAND HOSPITALS IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 289 FINLAND EXOSOME RESEARCH PRODUCTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND)
TABLE 290 DENMARK EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 291 DENMARK CONSUMABLES IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 292 DENMARK KITS & REAGENTS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 293 DENMARK INSTRUMENTS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 294 DENMARK EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND)
TABLE 295 DENMARK CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND)
TABLE 296 DENMARK NON-CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND)
TABLE 297 DENMARK EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 298 DENMARK THERAPEUTICS IN EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 299 DENMARK DIAGNOSIS IN EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 300 DENMARK EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 301 DENMARK PHARMACEUTICAL & BIOTECHNOLOGY COMPANY IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 302 DENMARK RESEARCH CENTERS IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 303 DENMARK ACADEMIC INSTITUTES IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 304 DENMARK CLINICAL TESTING LABORATORY IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 305 DENMARK HOSPITALS IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 306 DENMARK EXOSOME RESEARCH PRODUCTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND)
TABLE 307 REST OF EUROPE EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
図表一覧
FIGURE 1 EUROPE EXOSOME RESEARCH PRODUCTS MARKET: SEGMENTATION
FIGURE 2 EUROPE EXOSOME RESEARCH PRODUCTS MARKET: DATA TRIANGULATION
FIGURE 3 EUROPE EXOSOME RESEARCH PRODUCTS MARKET: DROC ANALYSIS
FIGURE 4 EUROPE EXOSOME RESEARCH PRODUCTS MARKET: EUROPE VS REGIONAL MARKET ANALYSIS
FIGURE 5 EUROPE EXOSOME RESEARCH PRODUCTS MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 EUROPE EXOSOME RESEARCH PRODUCTS MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 EUROPE EXOSOME RESEARCH PRODUCTS MARKET: DBMR MARKET POSITION GRID
FIGURE 8 EUROPE EXOSOME RESEARCH PRODUCTS MARKET: MARKET APPLICATION COVERAGE GRID
FIGURE 9 EUROPE EXOSOME RESEARCH PRODUCTS MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 EUROPE EXOSOME RESEARCH PRODUCTS MARKET: SEGMENTATION
FIGURE 11 THE INCREASE IN THE PREVALENCE OF CANCER AND OTHER AUTO-IMMUNE DISEASE IS EXPECTED TO DRIVE THE EUROPE EXOSOME RESEARCH PRODUCTS MARKET GROWTH IN THE FORECAST PERIOD
FIGURE 12 THE CONSUMABLES SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE EUROPE EXOSOME RESEARCH PRODUCTS MARKET IN 2023 & 2030
FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE EUROPE EXOSOME RESEARCH PRODUCTS MARKET
FIGURE 14 EUROPE EXOSOME RESEARCH PRODUCTS MARKET: BY PRODUCT, 2022
FIGURE 15 EUROPE EXOSOME RESEARCH PRODUCTS MARKET: BY PRODUCT, 2023-2030 (USD THOUSAND)
FIGURE 16 EUROPE EXOSOME RESEARCH PRODUCTS MARKET: BY PRODUCT, CAGR (2023-2030)
FIGURE 17 EUROPE EXOSOME RESEARCH PRODUCTS MARKET: BY PRODUCT, LIFELINE CURVE
FIGURE 18 EUROPE EXOSOME RESEARCH PRODUCTS MARKET: BY INDICATION, 2022
FIGURE 19 EUROPE EXOSOME RESEARCH PRODUCTS MARKET: BY INDICATION, 2023-2030 (USD THOUSAND)
FIGURE 20 EUROPE EXOSOME RESEARCH PRODUCTS MARKET: BY INDICATION, CAGR (2023-2030)
FIGURE 21 EUROPE EXOSOME RESEARCH PRODUCTS MARKET: BY INDICATION, LIFELINE CURVE
FIGURE 22 EUROPE EXOSOME RESEARCH PRODUCTS MARKET: BY APPLICATION, 2022
FIGURE 23 EUROPE EXOSOME RESEARCH PRODUCTS MARKET: BY APPLICATION, 2023-2030 (USD THOUSAND)
FIGURE 24 EUROPE EXOSOME RESEARCH PRODUCTS MARKET: BY APPLICATION, CAGR (2023-2030)
FIGURE 25 EUROPE EXOSOME RESEARCH PRODUCTS MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 26 EUROPE EXOSOME RESEARCH PRODUCTS MARKET: BY END USER, 2022
FIGURE 27 EUROPE EXOSOME RESEARCH PRODUCTS MARKET: BY END USER, 2023-2030 (USD THOUSAND)
FIGURE 28 EUROPE EXOSOME RESEARCH PRODUCTS MARKET: BY END USER, CAGR (2023-2030)
FIGURE 29 EUROPE EXOSOME RESEARCH PRODUCTS MARKET: BY END USER, LIFELINE CURVE
FIGURE 30 EUROPE EXOSOME RESEARCH PRODUCTS MARKET: BY DISTRIBUTION CHANNEL, 2022
FIGURE 31 EUROPE EXOSOME RESEARCH PRODUCTS MARKET: BY DISTRIBUTION CHANNEL, 2023-2030 (USD THOUSAND)
FIGURE 32 EUROPE EXOSOME RESEARCH PRODUCTS MARKET: BY DISTRIBUTION CHANNEL, CAGR (2023-2030)
FIGURE 33 EUROPE EXOSOME RESEARCH PRODUCTS MARKET : BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 34 EUROPE EXOSOME RESEARCH PRODUCTS MARKET: SNAPSHOT (2022)
FIGURE 35 EUROPE EXOSOME RESEARCH PRODUCTS MARKET: BY COUNTRY (2022)
FIGURE 36 EUROPE EXOSOME RESEARCH PRODUCTS MARKET: BY COUNTRY (2023 & 2030)
FIGURE 37 EUROPE EXOSOME RESEARCH PRODUCTS MARKET: BY COUNTRY (2022 & 2030)
FIGURE 38 EUROPE EXOSOME RESEARCH PRODUCTS MARKET: PRODUCT (2023-2030)
FIGURE 39 EUROPE EXOSOME RESEARCH PRODUCTS MARKET: COMPANY SHARE 2022 (%)
調査方法
データ収集と基準年分析は、大規模なサンプル サイズのデータ収集モジュールを使用して行われます。この段階では、さまざまなソースと戦略を通じて市場情報または関連データを取得します。過去に取得したすべてのデータを事前に調査および計画することも含まれます。また、さまざまな情報ソース間で見られる情報の不一致の調査も含まれます。市場データは、市場統計モデルと一貫性モデルを使用して分析および推定されます。また、市場シェア分析と主要トレンド分析は、市場レポートの主要な成功要因です。詳細については、アナリストへの電話をリクエストするか、お問い合わせをドロップダウンしてください。
DBMR 調査チームが使用する主要な調査方法は、データ マイニング、データ変数が市場に与える影響の分析、および一次 (業界の専門家) 検証を含むデータ三角測量です。データ モデルには、ベンダー ポジショニング グリッド、市場タイムライン分析、市場概要とガイド、企業ポジショニング グリッド、特許分析、価格分析、企業市場シェア分析、測定基準、グローバルと地域、ベンダー シェア分析が含まれます。調査方法について詳しくは、お問い合わせフォームから当社の業界専門家にご相談ください。
カスタマイズ可能
Data Bridge Market Research は、高度な形成的調査のリーダーです。当社は、既存および新規のお客様に、お客様の目標に合致し、それに適したデータと分析を提供することに誇りを持っています。レポートは、対象ブランドの価格動向分析、追加国の市場理解 (国のリストをお問い合わせください)、臨床試験結果データ、文献レビュー、リファービッシュ市場および製品ベース分析を含めるようにカスタマイズできます。対象競合他社の市場分析は、技術ベースの分析から市場ポートフォリオ戦略まで分析できます。必要な競合他社のデータを、必要な形式とデータ スタイルでいくつでも追加できます。当社のアナリスト チームは、粗い生の Excel ファイル ピボット テーブル (ファクト ブック) でデータを提供したり、レポートで利用可能なデータ セットからプレゼンテーションを作成するお手伝いをしたりすることもできます。
